000075502 001__ 75502
000075502 005__ 20200117221654.0
000075502 0247_ $$2doi$$a10.1016/S0167-8140(18)31970-4
000075502 0248_ $$2sideral$$a107939
000075502 037__ $$aART-2018-107939
000075502 041__ $$aeng
000075502 100__ $$aMolina Osorio, J.G.
000075502 245__ $$aSuperficial radiotherapy as haemostatic treatment in breast cancer
000075502 260__ $$c2018
000075502 5060_ $$aAccess copy available to the general public$$fUnrestricted
000075502 5203_ $$aPoster Session [EP-1661]
Purpose or Objective Breast cancer is a common pathology in which <10% of cases at the moment of diagnosis are considered to be locally advanced. In patients with locally advanced breast cancer who have deterioration in overall condition, with local growth and secondary bl eeding that are not subsidiary to surgery or other systemic therapies, superficial radiotherapy may be considered as an option in the treatment of these patients Objectives: It is described a number of cases with patients with locally advanced breast cance r with secondary bleeding who were treated with superficial radiotherapy for haemostatic purposes Material and Methods For a period from May 2016 to August 2017, 6 patients with locally advanced breast cancer who did not respond to systemic treatment or d ue to the disease or comorbidities associated were not candidates for that, who presented tumour growth with secondary bleeding and they were not subsidiaries of surgery. Superficial radiotherapy were administrated by a low energy X -Ray machine, with a tot al dose of 50 - 60Gy, divided in 1 -2 fractions per week. The haemostatic effect was value at the end of treatment. Results The average age was 73 years, most patients presented a grade 2 functional status (ECOG2). At the end of treatment, was objected a decrease of > o = 25% in tumor size and absence of bleeding was observed. Conclusion Surface radiotherapy is a treatment modality that should be taken into account in patients with breast cancer who present bleeding as a consequence of local tumor growth, given that this is a treatment comfortable for the patient, non invasive and increases the quality of patient’s life.
000075502 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000075502 590__ $$a5.252$$b2018
000075502 591__ $$aRADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING$$b14 / 129 = 0.109$$c2018$$dQ1$$eT1
000075502 591__ $$aONCOLOGY$$b46 / 229 = 0.201$$c2018$$dQ1$$eT1
000075502 592__ $$a2.023$$b2018
000075502 593__ $$aHematology$$c2018$$dQ1
000075502 593__ $$aRadiology, Nuclear Medicine and Imaging$$c2018$$dQ1
000075502 593__ $$aOncology$$c2018$$dQ1
000075502 655_4 $$ainfo:eu-repo/semantics/conferenceObject$$vinfo:eu-repo/semantics/publishedVersion
000075502 700__ $$aIbáñez Carreras, R.$$uUniversidad de Zaragoza
000075502 700__ $$aGarcía Gímeno, B.
000075502 700__ $$aLanzuela Valero, M.
000075502 700__ $$aMuñoz Saenz, E.
000075502 700__ $$aSanagustín Piedrafita, P.
000075502 700__ $$aMiranda Burgos, A.
000075502 700__ $$aMéndez Villamón, A.
000075502 700__ $$aPuertas Valiño, M.M.
000075502 700__ $$aEscuin, C.
000075502 700__ $$aGarcía Aguilera, C.
000075502 700__ $$aPonce Ortega, J.
000075502 700__ $$aAlled, L.
000075502 700__ $$aGascón Ferrer, M.
000075502 700__ $$aTejedor Gutierrez, M.
000075502 7102_ $$11010$$2770$$aUniversidad de Zaragoza$$bDpto. Pediatría Radiol.Med.Fís$$cÁrea Radiol. y Medicina Física
000075502 773__ $$g127, Suppl. 1 (2018), S893$$pRadiother. oncol.$$tRADIOTHERAPY AND ONCOLOGY$$x0167-8140
000075502 8564_ $$s606758$$uhttps://zaguan.unizar.es/record/75502/files/texto_completo.pdf$$yVersión publicada
000075502 8564_ $$s118260$$uhttps://zaguan.unizar.es/record/75502/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000075502 909CO $$ooai:zaguan.unizar.es:75502$$particulos$$pdriver
000075502 951__ $$a2020-01-17-22:10:22
000075502 980__ $$aARTICLE